Medication info
NeuBigsagen (Memantine Hydrochloride)

NeuBigsagen (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
White rectangular film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202002148 · Approved 2020.03.27 · Insurance code 646004930

Summary

Main use
Treatment of moderate to severe Alzheimer’s disease
Who takes it
Adults
Adult dose
This drug is administered orally once daily at the same time each day. If necessary, it may be administered twice daily. This drug may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1~7) Administer 5mg daily for 7 days. Week 2 (Days 8~14) Administer 10mg daily for 7 days. Week 3 (Days 15~21) Administer 15mg daily for 7 days. From week 4 onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg per day. 2. Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg per day. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg per day according to the standard dose-escalation regimen. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer’s disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

This drug is administered orally once daily at the same time each day. If necessary, it may be administered twice daily. This drug may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows, until the maintenance dose is reached. Week 1 (Days 1~7) Administer 5mg daily for 7 days. Week 2 (Days 8~14) Administer 10mg daily for 7 days. Week 3 (Days 15~21) Administer 15mg daily for 7 days. From week 4 onward Administer 20mg daily. Maintenance dose: The recommended maintenance dose is 20mg per day. 2. Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg per day. 3. Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg per day according to the standard dose-escalation regimen. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment: No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this drug.

Precautions

This medication should not be used in patients with hypersensitivity to the ingredients or those with severe liver or kidney dysfunction. It must be administered with caution in patients with epilepsy or a history of seizures, and those taking certain NMDA antagonists. In addition, patients expected to have changes in urinary acidity or those with recent heart disease should be careful. When taking this medication, side effects such as dizziness, headaches, constipation, drowsiness, and hypertension may occur. If symptoms worsen, consult a healthcare professional. There may be interactions with other medications, so it is essential to inform your doctor, especially if taking NMDA antagonists, antipsychotic drugs, muscle relaxants, or anticoagulants. Women who are pregnant or breastfeeding should carefully consider the use of this medication, as it may affect the fetus or infant, and discontinuing breastfeeding is recommended. The safety and efficacy of this medication in children or adolescents under 18 years of age have not been established. In cases of overdose, central nervous system symptoms or gastrointestinal symptoms may appear, and immediate medical attention should be sought if suspected. This medication may affect patients' concentration and reaction speed, so caution is advised when driving or operating machinery. Store this medication out of reach of children and keep it in its original container for safety.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • drowsiness
  • confusion
  • hallucination
Show 36 more
  • psychotic reaction
  • dizziness
  • balance disorder
  • gait abnormality
  • seizure
  • heart failure
  • hypertension
  • venous thrombosis/thromboembolism
  • dyspnea
  • constipation
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • headache
  • fatigue
  • malaise
  • weakness
  • diarrhea
  • confusion
  • drowsiness
  • drowsiness
  • dizziness
  • agitation
  • aggression
  • hallucination
  • gait disturbance
  • vomiting
  • diarrhea
  • restlessness
  • psychosis
  • visual hallucination
  • convulsion
  • drowsiness
  • confusion
  • unconsciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1°C and 30°C to preserve the medication's effectiveness.

Appearance and packaging

Appearance

White rectangular film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.